09-OCT-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1157 20 1044 87 1059 176 1071
ERLYTX 75 1 52 3 37 7 43
GI 161 1 52 13 158 26 158
GU 394 9 470 43 524 93 566
LEUK 161 3 157 16 195 30 183
LUNG 205 2 104 13 158 26 158
LYMPH 428 9 470 36 438 70 426
MELAN 8 0 0 1 12 1 6
MMYEL 116 2 104 16 195 20 122
MULT 51 1 52 2 24 3 18
OTHER 43 0 0 1 12 3 18
Total 2799 48 2505 231 2812 455 2769

09-OCT-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 212 4 209 21 256 37 225
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 5 0 0 2 24 3 18
LEUK 616 9 470 57 694 107 651
LUNG 372 9 470 45 548 67 408
LYMPH 1 1 52 1 12 1 6
OTHER 15 0 0 2 24 6 37
PEOLC 67 3 157 3 37 3 18
PREV 230 3 157 20 244 28 170
SXQOL 659 9 470 53 645 102 621
Total 2180 38 1985 204 2484 355 2160

09-OCT-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1157 20 1044 87 1059 176 1071
CCD 212 4 209 21 256 37 225
ERLYTX 77 1 52 3 37 7 43
GI 162 1 52 13 158 27 164
GU 399 9 470 45 548 96 584
LEUK 777 12 626 73 889 137 834
LUNG 577 11 574 58 706 93 566
LYMPH 429 10 522 37 450 71 432
MELAN 8 0 0 1 12 1 6
MMYEL 116 2 104 16 195 20 122
MULT 51 1 52 2 24 3 18
OTHER 58 0 0 3 37 9 55
PEOLC 67 3 157 3 37 3 18
PREV 230 3 157 20 244 28 170
SXQOL 659 9 470 53 645 102 621
Total 4979 86 4489 435 5297 810 4929

09-OCT-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 708 13 678 50 609 97 590
ERLYTX 53 1 52 3 37 5 30
GI 124 1 52 9 110 21 128
GU 289 5 261 28 341 61 371
LEUK 99 0 0 7 85 15 91
LUNG 130 1 52 8 97 19 116
LYMPH 279 6 313 23 280 45 274
MELAN 8 0 0 1 12 1 6
MMYEL 66 2 104 10 122 11 67
MULT 21 1 52 2 24 2 12
OTHER 43 0 0 1 12 3 18
Total 1820 30 1564 142 1729 280 1703

09-OCT-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 156 1 52 15 183 26 158
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 5 0 0 2 24 3 18
LEUK 250 4 209 23 280 36 219
LUNG 228 7 365 31 377 44 268
LYMPH 1 1 52 1 12 1 6
OTHER 15 0 0 2 24 6 37
PEOLC 55 3 157 3 37 3 18
PREV 230 3 157 20 244 28 170
SXQOL 480 6 313 36 438 75 457
Total 1423 25 1305 133 1619 223 1357

09-OCT-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 905 18 939 74 901 143 871
CCD 171 1 52 11 134 22 134
ERLYTX 55 1 52 3 37 5 30
GI 138 0 0 10 122 27 164
GU 328 5 261 31 377 69 420
LEUK 352 4 209 30 365 51 310
LUNG 387 8 417 39 475 69 420
LYMPH 280 7 365 24 292 46 280
MELAN 8 0 0 1 12 1 6
MMYEL 66 2 104 10 122 11 67
MULT 42 0 0 4 49 10 61
OTHER 125 0 0 3 37 8 49
PEOLC 56 0 0 3 37 3 18
PREV 230 3 157 20 244 28 170
SXQOL 480 6 313 36 438 75 457
Total 3623 55 2869 299 3642 568 3457

09-OCT-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 995 20 1044 83 1011 165 1004
ERLYTX 71 1 52 3 37 7 43
GI 96 0 0 10 122 18 110
GU 285 9 470 34 414 68 414
LEUK 132 3 157 15 183 26 158
LUNG 181 2 104 12 146 24 146
LYMPH 355 9 470 34 414 59 359
MMYEL 103 2 104 15 183 19 116
MULT 51 1 52 2 24 3 18
Total 2269 47 2453 208 2534 389 2368

09-OCT-2026 6:12

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1898 37 1931 161 1960 298 1814
AFFIL 126 1 52 3 37 7 43
CCOP/NCORP 1219 17 887 111 1351 198 1205
Non-SWOG 1736 31 1618 160 1948 307 1869
Total 4979 86 4488 435 5296 810 4931

09-OCT-2026 6:12

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S2507 ALL/ALAL, KMT2A-trans, Blina +/- Revumenib 1 Y 22-SEP-26

09-OCT-2026 6:12

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
OTHER NRGGY026 Endomet, Stage I-IV, Pac/Car w/ HER HYL/PHE 1 E 29-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 1 E 28-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 2 E 28-SEP-26
SXQOL NRG-CC013 HN Squamous Cell, Rec Chemo, BMX 1 E 23-SEP-26
OTHER NRGHN009 HN, RT + HD Cisp vs RT + LD Cisp for SCCHN 1 E 02-OCT-26

09-OCT-2026 6:12

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 19
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 11
LUNG LUNGMAP NSCLC, Adv, Master 2 9
LUNG LUNGMAP NSCLC, Adv, Master 1 9
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 9
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 7
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 7
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 4
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 4
GU S2427 Blad, MIBC, RT + Pembrolizumab 1 4
PEOLC S1501 Breast Stg IV, Card Tox Obs and w/ Carvedilol 2 3